Belite Bio (BLTE) Non-cash Items (2020 - 2025)
Belite Bio (BLTE) recorded quarterly Non-cash Items of $2.3 million in Q4 2025, down 99.16% quarter-over-quarter from $273.4 million in Q4 2024, and down 99.16% on a YoY basis from $273.4 million in Q4 2024.
Belite Bio (BLTE) Non-cash Items (2020 - 2025) Analysis & Trends
Belite Bio's Non-cash Items history runs 6 years deep, the most recent figure standing at $2.3 million for Q4 2025.
- In Q4 2025, Non-cash Items fell 99.16% year-over-year to $2.3 million; the TTM figure through Dec 2025 stood at $2.3 million (down 99.16% YoY), while the FY2025 annual figure was $2.3 million, down 99.16% from the prior year.
- Non-cash Items was $2.3 million for Q4 2025 at Belite Bio, down from $273.4 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $273.4 million in Q4 2024 to a low of $2.3 million in Q4 2025.
- Historically, Non-cash Items has averaged $64.3 million across 5 years, with a median of $10.5 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Non-cash Items jumped 778.71% in 2024, then tumbled 99.16% in 2025.
- A 5-year view of Non-cash Items shows it stood at $4.5 million in 2021, then jumped by 133.77% to $10.5 million in 2022, then jumped by 197.04% to $31.1 million in 2023, then soared by 778.71% to $273.4 million in 2024, then sank by 99.16% to $2.3 million in 2025.
- The last three Non-cash Items figures came in at $2.3 million (Q4 2025), $273.4 million (Q4 2024), and $31.1 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.29 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Dec 31, 2024 | 273.36 Mn |
| Dec 31, 2024 | 273.36 Mn |
| Dec 31, 2023 | 31.11 Mn |
| Dec 31, 2023 | 31.11 Mn |
| Dec 31, 2022 | 10.47 Mn |
| Dec 31, 2022 | 10.47 Mn |
| Dec 31, 2021 | 4.48 Mn |
| Dec 31, 2021 | 4.48 Mn |
| Dec 31, 2020 | 7.83 Mn |
| Dec 31, 2020 | 7.83 Mn |